Donghui Cui

3.3k citations

59 papers · 2.2k · h-index 23

Impact in

Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
Endocrine and Autonomic Systems top 2%
- Circadian rhythm and melatonin

Papers in

Pharmacology 18
- Pharmacogenetics and Drug Metabolism 18
- Inflammatory mediators and NSAID effects 6
Materials Chemistry 13

Co-authors: Thomayant Prueksaritanont (8 shared papers)Kenneth C. Lasseter (4 shared papers)John J. Renger (7 shared papers)Tamara D. Cabalu (6 shared papers)Susan L. Garson (7 shared papers)Paul J. Coleman (7 shared papers)C. Meacham Harrell (7 shared papers)Christopher J. Winrow (7 shared papers)
Journals: Drug Metabolism and Disposition (19 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)Xenobiotica (3 papers)Rapid Communications in Mass Spectrometry (3 papers)Inorganic Chemistry Frontiers (2 papers)
Partner nations: United States China Germany

In The Last Decade

Donghui Cui

54 papers receiving 2.1k citations

Peers

Countries citing papers authored by Donghui Cui

Since Specialization

Citations

This map shows the geographic impact of Donghui Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donghui Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donghui Cui more than expected).

Fields of papers citing papers by Donghui Cui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donghui Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donghui Cui. The network helps show where Donghui Cui may publish in the future.

Co-authors

The 25 scholars most cited alongside Donghui Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Donghui Cui Line = papers co-authored together Donghui Cui links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Metabolism and Disposition in Humans of Raltegravir (MK-0518), an Anti-AIDS Drug Targeting the Human Immunodeficiency Virus 1 Integrase Enzyme Drug Metabolism and Disposition ·Kelem Kassahun, Ian McIntosh, Donghui Cui, David Hreniuk, Shelia Merschman, Kenneth C. Lasseter, Neal Azrolan, Marian Iwamoto, John A. Wagner, Larissa Wenning	2007	234
2	Promotion of Sleep by Suvorexant—A Novel Dual Orexin Receptor Antagonist Journal of Neurogenetics ·Christopher J. Winrow, Anthony L. Gotter, Christopher D. Cox, Scott M. Doran, Pamela L. Tannenbaum, Michael J. Breslin, Susan L. Garson, Steven V. Fox, C. Meacham Harrell, Joanne Stevens, Duane R. Reiss, Donghui Cui, Paul J. Coleman, John J. Renger	2011	233
3	Drug–Drug Interaction Studies: Regulatory Guidance and An Industry Perspective The AAPS Journal ·Thomayant Prueksaritanont, Xiaoyan Chu, Christopher R. Gibson, Donghui Cui, Ka Lai Yee, Jeanine Ballard, Tamara D. Cabalu, Jerome Hochman	2013	202
4	Metabolism and Disposition of Dasatinib after Oral Administration to Humans Drug Metabolism and Disposition ·Lisa J. Christopher, Donghui Cui, Chi‐Yuan Wu, Roger Luo, James Manning, Samuel J. Bonacorsi, Michael W. Lago, Alban J. Allentoff, Francis Y. F. Lee, Betty McCann, Susan Galbraith, Donald P. Reitberg, Kan He, Anthony Barros, Anne Blackwood‐Chirchir, W. Griffith Humphreys, Ramaswamy A. Iyer	2008	163
5	Pharmacokinetic Drug Interactions Involving 17??-Ethinylestradiol Clinical Pharmacokinetics ·Hongjian Zhang, Donghui Cui, Bonnie Wang, Yong–Hae Han, Praveen Balimane, Zheng Yang, Michael Sinz, A. David Rodrigues	2007	149
6	Pharmacological characterization of MK-6096 – A dual orexin receptor antagonist for insomnia Neuropharmacology ·Christopher J. Winrow, Anthony L. Gotter, Christopher D. Cox, Pamela L. Tannenbaum, Susan L. Garson, Scott M. Doran, Michael J. Breslin, John D. Schreier, Steven V. Fox, C. Meacham Harrell, Joanne Stevens, Duane R. Reiss, Donghui Cui, Paul J. Coleman, John J. Renger	2011	112
7	Identification of the major human liver cytochrome P450 isoform(s) responsible for the formation of the primary metabolites of ziprasidone and prediction of possible drug interactions British Journal of Clinical Pharmacology ·Chandra Prakash, Amin Kamel, Donghui Cui, Robert Whalen, J. Miceli, Donald Tweedie	2000	100
8	Metabolites of Caspofungin Acetate, a Potent Antifungal Agent, in Human Plasma and Urine Drug Metabolism and Disposition ·Suresh K. Balani, Xin Xu, Byron H. Arison, Maria V. Silva, (unknown), F A deLuna, Donghui Cui, Prasad H. Kari, Trung Ly, Cornelis E. C. A. Hop, Rominder Singh, Michael A. Wallace, Dennis Dean, J H Lin, Paul G. Pearson, Thomas A. Baillie	2000	92
9	The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold BMC Neuroscience ·Anthony L. Gotter, Christopher J. Winrow, Joseph Brunner, Susan L. Garson, Steven V. Fox, Jacquelyn Binns, C. Meacham Harrell, Donghui Cui, Ka Lai Yee, Mark Stiteler, Joanne Stevens, Alan T. Savitz, Pamela L. Tannenbaum, (unknown), Terrence P. McDonald, (unknown), Scott D. Kuduk, Jason M. Uslaner, Paul J. Coleman, John J. Renger	2013	81
10	Absorption, Metabolism, and Excretion of Etoricoxib, a Potent and Selective Cyclooxygenase-2 Inhibitor, in Healthy Male Volunteers Drug Metabolism and Disposition ·A. David Rodrigues, Rita A. Halpin, Leslie A. Geer, Donghui Cui, Eric Woolf, Catherine Z. Matthews, Keith Gottesdiener, Patrick Larson, Kenneth C. Lasseter, Nancy Agrawal	2003	67
11	Identification of the Human Enzymes Involved in the Oxidative Metabolism of Dasatinib: An Effective Approach for Determining Metabolite Formation Kinetics Drug Metabolism and Disposition ·Lifei Wang, Lisa J. Christopher, Donghui Cui, Wenying Li, Ramaswamy A. Iyer, W. Griffith Humphreys, Donglu Zhang	2008	62
12	Identification of in vitro metabolites of indinavir by “intelligent automated LC-MS/MS” (INTAMS) utilizing triple quadrupole tandem mass spectrometry Journal of the American Society for Mass Spectrometry ·Xiao Yu, Donghui Cui, Margaret R. Davis	1999	61
13	Confirmation That Cytochrome P450 2C8 (CYP2C8) Plays a Minor Role in (S)-(+)- and (R)-(-)-Ibuprofen Hydroxylation in Vitro Drug Metabolism and Disposition ·Shu‐Ying Chang, Wenying Li, Sarah C. Traeger, Bei Wang, Donghui Cui, Hongjian Zhang, Bo Wen, A. David Rodrigues	2008	53
14	In Vitro Assessment of Drug-Drug Interaction Potential of Boceprevir Associated with Drug Metabolizing Enzymes and Transporters Drug Metabolism and Disposition ·Xiaoyan Chu, Xiaoxin Cai, Donghui Cui, Cuyue Tang, Anima Ghosal, Grace Chan, Mitchell D. Green, Yuhsin Kuo, Yuexia Liang, Cheri M. Maciolek, Jairam Palamanda, Raymond Evers, Thomayant Prueksaritanont	2013	53
15	SULFOTRANSFERASE 1E1 IS A LOW KM ISOFORM MEDIATING THE 3-O-SULFATION OF ETHINYL ESTRADIOL Drug Metabolism and Disposition ·Michael Schrag, Donghui Cui, Thomas H. Rushmore, Magang Shou, Bennett Ma, A. David Rodrigues	2004	50
16	The Disposition and Metabolism of Rofecoxib, a Potent and Selective Cyclooxygenase-2 Inhibitor, in Human Subjects Drug Metabolism and Disposition ·Rita A. Halpin, Arturo G. Porras, Leslie A. Geer, Margaret R. Davis, Donghui Cui, George A. Doss, Eric Woolf, Donald G. Musson, Catherine Z. Matthews, Ralph S. Mazenko, Jules I. Schwartz, Kenneth C. Lasseter, Kamlesh P. Vyas, Thomas A. Baillie	2002	40
17	Biotransformation of [14C]Dasatinib: In Vitro Studies in Rat, Monkey, and Human and Disposition after Administration to Rats and Monkeys Drug Metabolism and Disposition ·Lisa J. Christopher, Donghui Cui, Wenying Li, Anthony Barros, Vinod Arora, Haiying Zhang, Lifei Wang, Donglu Zhang, James Manning, Kan He, Anthony M. Fletcher, Marc D. Ogan, Michael W. Lago, Samuel J. Bonacorsi, W. Griffith Humphreys, Ramaswamy A. Iyer	2008	35
18	In vitro and in vivo characterisation of the metabolism and disposition of suvorexant in humans Xenobiotica ·Donghui Cui, Tamara D. Cabalu, Ka Lai Yee, James H. Small, Xiaodong Li, Bo Liu, Cheri M. Maciolek, Sheri Smith, Wen Liu, Jacqueline B. McCrea, Thomayant Prueksaritanont	2016	33
19	Identification of drug metabolites in biological matrices by intelligent automated liquid chromatography/ tandem mass spectrometry Rapid Communications in Mass Spectrometry ·Linda Lopez, Xiao Yu, Donghui Cui, Margaret R. Davis	1998	32
20	Contribution of Metabolites to P450 Inhibition–Based Drug–Drug Interactions: Scholarship from the Drug Metabolism Leadership Group of the Innovation and Quality Consortium Metabolite Group Drug Metabolism and Disposition ·Hongbin Yu, Suresh K. Balani, Wei‐Chao Chen, Donghui Cui, Ling He, W. Griffith Humphreys, Jialin Mao, Weidong G. Lai, Anthony Lee, Heng‐Keang Lim, Christopher MacLauchlin, Chandra Prakash, Sekhar Surapaneni, Susanna Tse, Alana L. Upthagrove, Robert L. Walsky, Bo Wen, Zhaopie Zeng	2015	30

About Donghui Cui

Donghui Cui is a scholar working on Pharmacology, Materials Chemistry, Oncology, Renewable Energy, Sustainability and the Environment and Cognitive Neuroscience, having authored 59 papers that have together received 2.2k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (18 papers), Advanced Photocatalysis Techniques (10 papers), Drug Transport and Resistance Mechanisms (10 papers), Sleep and Wakefulness Research (8 papers), Sleep and related disorders (7 papers), Inflammatory mediators and NSAID effects (6 papers), Hepatitis C virus research (5 papers) and Circadian rhythm and melatonin (5 papers). The work is most often cited by research in Pharmacology (511 citations), Endocrine and Autonomic Systems (325 citations), Experimental and Cognitive Psychology (339 citations), Virology (111 citations) and Cognitive Neuroscience (458 citations). Donghui Cui has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Thomayant Prueksaritanont, Kenneth C. Lasseter, John J. Renger, Tamara D. Cabalu, Susan L. Garson, Paul J. Coleman, C. Meacham Harrell, Christopher J. Winrow, Ka Lai Yee and Steven V. Fox. Their work appears in journals such as Drug Metabolism and Disposition, Bioorganic & Medicinal Chemistry Letters, Xenobiotica, Rapid Communications in Mass Spectrometry and Inorganic Chemistry Frontiers.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Donghui Cui

Impact in

Papers in i

In The Last Decade

Donghui Cui

Peers

Countries citing papers authored by Donghui Cui

Fields of papers citing papers by Donghui Cui

All Works

About Donghui Cui

Explore authors with similar magnitude of impact

Papers in